Squeeze and Dose is an innovative dosing system designed to elevate the product experience. Engineered for precision and effortless, one-handed operation, it delivers clean, accurate dispensing that ...
Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced the launch of Premia ™ Precision, a new quality standard for elastomer components, ...
Aptar Beauty and BVLGARI won the Formes de Luxe Award 2026 in the Refill category. The Le Gemme Tygar Travel Spray is a custom luxury fragrance mini packaging based on the Nomad Refill technology.
Submit your email address below and stay up to date with the latest industry insights. *Required. For details about how your email address will be used, read our ...
(Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 3% and core sales increased 1% Reported net income ...
Crystal Lake, Illinois, May 1, 2025 — AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first ...
In India, semaglutide launch planning is closely tied to patent‑expiry timelines, and additional GLP‑1 programs are now approaching key filing milestones. Many of the teams running these programs are ...
Aptar Beauty releases a new white paper entitled “Winning Through Differentiation: How Custom Primary Packaging Is Becoming a Strategic Growth Lever for Beauty Brands.” This thought-leadership report ...
Crystal Lake, Illinois, February 6, 2025 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth ...
Collaboration - innovating alongside customers, suppliers, industry coalitions and nonprofits to enable progress toward their goals – as well as for better outcomes for people and our planet; and ...
Crystal Lake, Illinois, May 27, 2026 -- AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it ...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Crystal Lake, Illinois, July 15, 2025 – Aptar Pharma announces its acquisition of the clinical trial materials manufacturing capabilities of Mod3 Pharma (formerly Enteris Biopharma) from SWK Holdings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results